Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.41 |
| ▸ | MEN1 | O00255 | 7/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | FADS1 | O60427 | 1/20 | 0.37 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | PDE5A | O76074 | 1/20 | 0.37 |
| ▸ | VDR | P11473 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4043651 | 0.88 | L3MBTL1 (0.47) | L3MBTL1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL4042771 | 0.84 | UGCG (0.46) | KMT2AMEN1PDCD1CD274 | |
| SCHEMBL4042219 | 0.83 | UGCG (0.46) | KMT2AMEN1PDCD1CD274PDE5A | |
| SCHEMBL4043112 | 0.80 | CD274 (0.58) | KMT2AMEN1PDCD1CD274ALDH1A1 | |
| SCHEMBL4044542 | 0.79 | PDCD1 (0.39) | MAPTLMNAKMT2AMEN1PDCD1 | |
| SCHEMBL27580434 | 0.78 | MAPT (0.47) | L3MBTL1MAPTLMNAKMT2AMEN1 | |
| SCHEMBL4050443 | 0.76 | PDCD1 (0.48) | MAPTKMT2AMEN1PDCD1CD274 | |
| SCHEMBL4040485 | 0.76 | PDCD1 (0.42) | L3MBTL1LMNAKMT2AMEN1TDP1 | |
| SCHEMBL4039858 | 0.70 | UGCG (0.46) | L3MBTL1MAPTLMNATDP1PDCD1 | |
| SCHEMBL4043960 | 0.70 | CA12 (0.39) | L3MBTL1MAPTLMNAKMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2069022-A2 | AGENT FOR DYEING FIBERS COMPRISING KERATIN | Henkel AG & Co. KGaA (DE) | 2009-06-17 | — | — | EP | claimed |
| EP-1319659-B1 | TRIAZINONES AND MEDICINAL USE THEREOF | EISAI R&D MAN CO LTD (JP) | 2009-03-11 | — | — | EP | claimed |
| WO-2008074578-A2 | AGENT FOR DYEING FIBERS COMPRISING KERATIN | HENKEL AG & CO. KGAA (DE) | 2008-06-26 | — | — | WO | claimed |
| EP-1319659-A1 | PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF | Eisai Co., Ltd. (JP) | 2003-06-18 | — | — | EP | claimed |
| EP-2081543-A2 | BLEACHING AGENT COMPRISING PIPERIDONE/S AND IMIDAZOLE/S | Henkel AG & Co. KGaA (DE) | 2009-07-29 | — | — | EP | disclosed |
| EP-2051689-A1 | LIGHTENING AGENTS AND/OR DYES THAT CONTAIN ALDEHYDE(S) | Henkel AG & Co. KGaA (DE) | 2009-04-29 | — | — | EP | disclosed |
| EP-1319659-B1 | TRIAZINONES AND MEDICINAL USE THEREOF | EISAI R&D MAN CO LTD (JP) | 2009-03-11 | — | — | EP | disclosed |
| WO-2009027237-A2 | KIT FOR THE PROVISION OF COLORANTS | HENKEL AG & CO. KGAA (DE) | 2009-03-05 | — | — | WO | disclosed |
| WO-2008095558-A2 | BLEACHING AGENT COMPRISING PIPERIDONE/S AND IMIDAZOLE/S | HENKEL AG & CO. KGAA (DE) | 2008-08-14 | — | — | WO | disclosed |
| WO-2008019986-A1 | LIGHTENING AGENTS AND/OR DYES THAT CONTAIN ALDEHYDE(S) | HENKEL AG & CO. KGAA (DE) | 2008-02-21 | — | — | WO | disclosed |
| US-20060189622-A1 | Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| US-20030225081-A1 | Pyridazinones and triazinones and medicinal use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-12-04 | — | — | US | disclosed |
| EP-1319659-A1 | PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF | Eisai Co., Ltd. (JP) | 2003-06-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030225081-A1 | Pyridazinones and triazinones and medicinal use thereof | GRIK1, GRIK3, GRIK2 | L3MBTL1 3753/4885MAPT 4269/4885LMNA 2726/4885 |
| US-20060189622-A1 | Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations | GRIK3, GRIK1, GRIK2 | L3MBTL1 4350/4885MAPT 3873/4885LMNA 2181/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.